Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-012390

Chief Executive Officer sold 14,762 shares at $9.53 ($140,720)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
De Backer Marianne Chief Executive Officer 2026-02-24 Sale 10b5-1 −14,762 $9.53 $140,720 1,020,704 D
Open-market sales · 14,762 sh · avg $9.53 · $140,720
Loading xslF345X05/wk-form4_1772142870.xml…